Luis Gerardo Rodríguez‐Lobato

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

Aina Oliver‐Caldés, Verónica González‐Calle, Valentín Cabañas et al. · The Lancet Oncology · 2023 · 87 citations · Full text

Medicine, Hematology, Immunology +17

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira et al. · Leukemia · 2018 · 65 citations

Medicine, Hematology, Oncology +14

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Benedetto Bruno, Ralph Wäsch, Monika Engelhardt et al. · Haematologica · 2021 · 53 citations · Full text

Medicine, Hematology, Oncology +17

Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation

Alexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez‐Lobato et al. · Transplantation and Cellular Therapy · 2023 · 52 citations · Full text

Life Sciences, Immunology, Inflammation +16

Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma

Ester Lozano, Mari-Pau Mena, Tania Díaz et al. · Clinical Cancer Research · 2020 · 48 citations · Full text

Life Sciences, Immunology, Oncology +15